bioMérieux S.A. (EPA:BIM)
France · Delayed Price · Currency is EUR 70.70
-1.15 (-1.60%)
Jul 31, 2026, 1:04 PM CET
bioMérieux Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 657.7 | 569.8 | 449.8 | 352.4 | 552.6 | 803.5 |
Cash & Short-Term Investments | 657.7 | 569.8 | 449.8 | 352.4 | 552.6 | 803.5 |
Cash Growth | 15.43% | 26.68% | 27.64% | -36.23% | -31.23% | 106.45% |
Accounts Receivable | 715.3 | 766.2 | 792.3 | 728.6 | 740.1 | 590.6 |
Other Receivables | 246.8 | 244.7 | 221.8 | 215.7 | 186.8 | 170.4 |
Total Trade Receivables | 962.1 | 1,011 | 1,014 | 944.3 | 926.9 | 761 |
Inventory | 975.3 | 959.7 | 1,037 | 908.5 | 737.2 | 620 |
Other Current Assets | - | 0 | 0 | 0 | 0 | 8 |
Total Current Assets | 2,595 | 2,540 | 2,501 | 2,205 | 2,217 | 2,185 |
Net Property, Plant & Equipment | 1,709 | 1,657 | 1,696 | 1,506 | 1,370 | 1,225 |
Other Intangible Assets | 415.1 | 401.5 | 492 | 528.6 | 625 | 411.5 |
Goodwill | 757.1 | 727.8 | 730.4 | 698.8 | 812.5 | 669.5 |
Long-Term Investments | 121.8 | 129.4 | 195.8 | 220.2 | 91 | 62 |
Other Long-Term Assets | 95.5 | 118.4 | 155 | 100.4 | 71.6 | 44.6 |
Total Assets | 5,694 | 5,575 | 5,770 | 5,259 | 5,187 | 4,605 |
Accounts Payable | 252.1 | 262.1 | 272.4 | 265.1 | 269.4 | 239.5 |
Accrued Expenses | 514.3 | 539.4 | 574.2 | 495.9 | 507.9 | 448.5 |
Short-Term Debt | 233.2 | 131.4 | 141.5 | 163.4 | 187 | 99.7 |
Other Current Liabilities | 128.1 | 131.8 | 146.8 | 162.9 | 166.9 | 168.2 |
Total Current Liabilities | 1,128 | 1,065 | 1,135 | 1,087 | 1,131 | 955.8 |
Long-Term Debt | 188.6 | 330 | 349.2 | 355.4 | 318.4 | 362.8 |
Other Long-Term Liabilities | 78.3 | 74 | 74.9 | 64.4 | 94.1 | 122.8 |
Total Long-Term Liabilities | 266.9 | 404 | 424.1 | 419.7 | 412.5 | 485.6 |
Total Liabilities | 1,395 | 1,469 | 1,559 | 1,507 | 1,544 | 1,441 |
Common Stock | 12 | 12 | 12 | 12 | 12 | 12 |
Additional Paid-in Capital | 4,059 | 3,693 | 3,761 | 3,383 | 3,140 | 2,499 |
Retained Earnings | 226.1 | 397.5 | 432.2 | 357.6 | 452.4 | 601.1 |
Total Common Shareholders' Equity | 4,297 | 4,102 | 4,205 | 3,752 | 3,604 | 3,112 |
Minority Interest | 2.1 | 3.9 | 6.1 | 0 | 38.7 | 51.4 |
Shareholders' Equity | 4,299 | 4,106 | 4,211 | 3,752 | 3,643 | 3,164 |
Total Liabilities & Equity | 5,694 | 5,575 | 5,770 | 5,259 | 5,187 | 4,605 |
Total Debt | 421.8 | 461.4 | 490.7 | 518.8 | 505.4 | 462.5 |
Net Cash (Debt) | 235.9 | 108.4 | -40.9 | -166.4 | 47.2 | 341 |
Net Cash Growth | 117.62% | - | - | - | -86.16% | - |
Net Cash Per Share | 1.99 | 0.91 | -0.34 | -1.40 | 0.40 | 2.87 |
Book Value | 4,297 | 4,102 | 4,205 | 3,752 | 3,604 | 3,112 |
Book Value Per Share | 36.24 | 34.52 | 35.40 | 31.58 | 30.43 | 26.18 |
Tangible Book Value | 3,125 | 2,973 | 2,983 | 2,525 | 2,167 | 2,031 |
Tangible Book Value Per Share | 26.35 | 25.01 | 25.11 | 21.25 | 18.29 | 17.08 |